Haleon: latest retail news and insights | ESM Magazine

Haleon Posts Tepid Q1 Sales As Demand For Some Products Cool Off

Consumer healthcare company Haleon reported first-quarter revenue slightly below market estimates as volumes declined.

Sensodyne-Maker Haleon To Shut UK Manufacturing Site, With More Than 400 Jobs Hit

Consumer healthcare company Haleon is planning to shut down its manufacturing site in Britain by 2026, which will impact 435 jobs, a spokesperson told Reut...

Haleon Names Dawn Allen As New Finance Chief

Consumer healthcare firm Haleon has appointed Tate & Lyle executive Dawn Allen as its new chief financial officer, effective 1 November 2024.

Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon To 24%

Consumer healthcare firm Haleon has said that U.S. drugmaker Pfizer, its top shareholder, will sell down its stake in the company to about 24%.

Haleon Reports Sluggish First-Quarter Growth

Despite price increases, Haleon's roster of products has largely kept cheaper private-label competition at bay, although the cost-of-living squeeze and com...

Haleon To Sell ChapStick To Yellow Wood For About €468m

Britain's Haleon said it had agreed to sell lip balm brand ChapStick to a company owned by private equity firm Yellow Wood Partners.

Sir Dave Lewis Named Operating Advisor To CD&R Funds

US investment firm Clayton, Dubilier & Rice (CD&R) has appointed Sir Dave Lewis as an operating advisor to CD&R funds.

Haleon Misses Revenue Estimates As North America Demand Drags

Haleon missed market estimates for third-quarter revenue, as the world's largest consumer healthcare firm grappled with weak demand for its painkillers, di...